Our new 2013 promo flyer describing the services we can offer biotech and pharma companies.

1. SciBite - From Molecule To Merger
PHARMA & BIOTECH INTELLIGENCE SOLUTIONS
Understanding The Therapeutic Landscape
SciBite provides a powerful new approach to competitor intelligence and opportunity spotting
within drug discovery. Our combination of advanced semantic text analysis and crowd-
sourced, community trends provides you with a unique perspective on drugs, companies,
targets and indications across patents, papers, clinical trials, grants, news and social media. All of
this is live, updated continuously – you’ll never miss the next big thing!
SciBite is essentially a large database of every recent article of relevance to drug discovery,
accurately tagged with critical concepts. The system excels at:
¤ INFORMING SCIENTISTS & BUSINESS ANALYSTS
SCIBITE.COM: Live Pharma Intelligence SCIBITE-PLUS: Coming Soon!
Keep up to date with the latest Cutting-edge analytics to
Drug Discovery trends. provide deep insight into
Literature, Patents, Grants, new therapeutic
Clinical Trials, Blogs, News, opportunities and
Tweets and more, all in one competitor activity. All from
place! a single, web-based
dashboard
¤ ENABLING INFORMATICIANS AND DATA MINERS
THE SCIBITE API “TERMITE” – TEXT MINING TOOL
Class-leading text-mining
Access all of our data for your software and entity
own data mining. Find and recogniser. Semantic
mine new connections markup of documents and
between drugs, companies, improve search engine
targets and indications. performance. Best in class
thesauri.
¤ ENHANCING YOUR INTERNAL INFORMATION SYSTEMS
SCIBITE WIDGETS SCIBITE DATA
Embed live news into your own Access the full SciBite
applications, provide your dataset and connect the
scientists with instant, relevant rich information on the drug
updates. Simple, standards- discovery landscape into
based integration. your internal network
Contact us today to discuss how your organisation can keep track of new developments for the
therapy areas and targets you care about. Take a look at: http://scibite.com.
To contact us, please visit: http://scibite.com/talk.html
Page 1 of 2
© 2013 SciBite Limited. Registered In England & Wales No. 7778456
Contact us via http://scibite.com/talk.html
http://about.scibite.com @Scibitely

2. SciBite - From Molecule To Merger
¤ SOURCES - SCANNED EVERY MINUTE, EVERY DAY
No other system provides as broad coverage, in real time!
Name Description
MEDLINE Broad coverage of the biomedical published literature
CLINICALTRIALS.GOV Clinical trials database from the US NIH
ISRCTN World-wide clinical trials database
EUCTR European clinical trials register
PATENTS WO, EP and US office life science and clinical patents
GRANTS New grant awards in the US from the NIH
NEWS Latest stories from thousands of government, industry and media websites
SOCIAL Latest blog posts and tweets from key figures in the industry
REAGENTS Biologically relevant chemicals
¤ MAJOR ENTITIES (CONCEPTS) COVERED
Code Description Links To Public IDs?
GENE Human gene/proteins Yes (HGNC)
PROTYP Protein Types (Families) Yes (HGNC)
INDICATION Human disease/indication Yes (MeSH)
COMPANY Pharma/Biotech companies No (SciBite Proprietary)
DRUG Known drugs (clinical, development & discovery) Yes (ChEMBL)
MIRNA MicroRNAs Yes (mirBase)
MUTATION Protein Mutations No (Not applicable)
RESCODE Drug research codes Yes (ChEMBL)
BIOCHEM Biologically relevant chemicals Yes (MeSH)
We use extensive synonym collections (‘thesauri”) to scan every article we see for mentions of critical drug discovery
topics. Many of these are based on public sources, designed to facilitate integration with other data. However, they are
extensively curated and validated to compensate for the many missing or ambiguous terms found in raw sources. Our
Protein Family collection covers high-level molecule groups (such as ‘Interleukins’, ‘Cytokines’, ‘DNA Methylases’)
capturing far more than traditional gene-centric approaches. We believe our thesauri give us, and potentially you, a clear
advantage.
¤ WHAT CAN I DO WITH IT ALL?
Our unparalleled combination of data mining and crowd-sourced social trends results in a powerful dataset for
understanding the latest “hot” areas in drug discovery. By viewing our data in different ways you can understand
competitor activity, look for new targets for an indication, find new biomarkers or biological approaches, monitor drug
failures, identify trends and much more. Here are just some of the many ways to view our data:
Heat maps differentiate novel
and precedented approaches
Time
Target
Trend Plots pick out
topics peaking in activity Publications/year for GEO tagging shows
breast cancer targets
who’s working on what,
and where.
ABOUT SCIBITE
SciBite is led by scientists with many years experience analysing and acting on competitor intelligence within big
pharma. We believe that our unique approach opens up access to this type of data to a wider audience and provides
new opportunities to understand the ever-changing therapeutic landscape.
Page 2 of 2
© 2013 SciBite Limited. Registered In England & Wales No. 7778456
Contact us via http://scibite.com/talk.html
http://about.scibite.com @Scibitely